Literature DB >> 4130309

Alginate-antacid in the reduction of gastro-oesophageal reflux.

C Stanciu, J R Bennett.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4130309     DOI: 10.1016/s0140-6736(74)92340-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  23 in total

1.  Vestibular reactions associated with minocycline.

Authors:  J A Jacobson; B Daniel
Journal:  Antimicrob Agents Chemother       Date:  1975-10       Impact factor: 5.191

2.  Reflux esophagitis.

Authors:  W J Dodds; W J Hogan; W N Miller
Journal:  Am J Dig Dis       Date:  1976-01

3.  Letter: Diagnosis of "reflux oesophagitis".

Authors:  M Yunus; J R Bennett
Journal:  Br Med J       Date:  1975-04-26

4.  Gaviscon and Carobel compared with cisapride in gastro-oesophageal reflux.

Authors:  P Greally; F J Hampton; U M MacFadyen; H Simpson
Journal:  Arch Dis Child       Date:  1992-05       Impact factor: 3.791

5.  24-hour esophageal pH monitoring before and after medical therapy for reflux esophagitis.

Authors:  D A Lieberman
Journal:  Dig Dis Sci       Date:  1988-02       Impact factor: 3.199

6.  Reproducibility of ambulatory oesophageal pH monitoring.

Authors:  F Johnsson; B Joelsson
Journal:  Gut       Date:  1988-07       Impact factor: 23.059

7.  Medical management of heartburn.

Authors: 
Journal:  Br Med J       Date:  1974-10-12

8.  [Applications of endoscopy, manometry, and conservative therapy (author's transl)].

Authors:  M Wienbeck
Journal:  Langenbecks Arch Chir       Date:  1974

9.  Controlled trial of a new dosage form of carbenoxolone (Pyrogastrone) in the treatment of reflux esophagitis.

Authors:  P I Reed; W A Davies
Journal:  Am J Dig Dis       Date:  1978-02

Review 10.  Carbenoxolone: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; R Spencer; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.